| 000 | 01877 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515220810.0 | ||
| 264 | 0 | _c20100907 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2010.03.051 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHua, Wen-Feng | |
| 245 | 0 | 0 |
_aCurcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cJul 2010 |
||
| 300 |
_a16-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xenzymology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 | _aEnhancer of Zeste Homolog 2 Protein |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aPolycomb Repressive Complex 2 |
| 650 | 0 | 4 |
_aTranscription Factors _xbiosynthesis |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
| 700 | 1 | _aFu, Yong-Shui | |
| 700 | 1 | _aLiao, Yi-Ji | |
| 700 | 1 | _aXia, Wen-Jie | |
| 700 | 1 | _aChen, Yang-Chao | |
| 700 | 1 | _aZeng, Yi-Xin | |
| 700 | 1 | _aKung, Hsiang-Fu | |
| 700 | 1 | _aXie, Dan | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 637 _gno. 1-3 _gp. 16-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2010.03.051 _zAvailable from publisher's website |
| 999 |
_c19744135 _d19744135 |
||